Texas Judge Strikes Down FDA’s Regulation of Laboratory-Developed Tests, Boosting Patient Access and Innovation April 2, 2025
Court Overturns FDA Regulation on Laboratory Developed Tests, Preserves Patient Access to Essential Diagnostic Services April 2, 2025
Trump Administration’s Abrupt Overhaul: 10,000 Layoffs Shake HHS Amid Controversy and Chaos April 1, 2025
Airna’s $155 Million Boost: Pioneering RNA Editing for a Breakthrough in Alpha-1 Antitrypsin Deficiency April 1, 2025
A Critical Crossroad: The Impact of Peter Marks’ Departure on Cell and Gene Therapy Development April 1, 2025
A Pivotal Shift: The Departure of Peter Marks and Its Implications for Cell and Gene Therapy Development April 1, 2025
Navigating Uncertainty: The Future of Cell and Gene Therapy After Peter Marks’ Departure March 31, 2025
Vaccine Markets in Turmoil: Peter Marks Resigns Amidst Controversial Leadership Changes at HHS March 31, 2025
Unlocking the Future of Biomarker Research: The Power of Expert-Curated Data Platforms March 31, 2025
